Good points, Im definitely seeing it from glass half empty perspective, there are positives. However MXC did not give 60%+ equity in the placement on LSE , like MDC is proposing.
Does have benefits, however there is a lot of red tape involved, and will be a long while until its listed on nasdaq, look at IHL, a year after they announced intention of listing on nasdaq in Feb 2021 and had already appointed a well known firm to facilitate it, and it was over a year later that they were actually listed. We have not even got shareholder approval yet, let alone appointed anyone to undertake it, so we are looking at a long way off getting listing here.
Im sure there will be a pump once it is listed like there has been with IHL and MXC (both these companies back down to under pre listing prices now though.) So maybe we are looking at holding for another year or so, and get some gains on the pump on listing. In the meantime however remember that shares being bought now will be losing 63% of equity in the company on the IPO. Will be interesting to see how the market reacts tomorrow.
MDC Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
(20min delay)